1. Acadia Healthcare reaffirms commitment to long-term shareholder value. 2. Focused on disciplined growth and operational efficiency in behavioral healthcare. 3. Goldman Sachs and J.P. Morgan are financial advisors for Acadia. 4. Acadia operates 274 facilities, serving over 82,000 patients daily. 5. Forward-looking statements highlight risks related to external factors.
Acadia's commitment to enhancing shareholder value and operational efficiency is likely to instill investor confidence. Historically, firms showcasing strong growth strategies, like Acadia, have seen positive stock responses, especially in stabilizing sectors such as healthcare.
The article presents key corporate strategies and commitments that could shape ACHC's future performance. Enhanced shareholder communication and operational strategies can have a substantial impact on stock price movements.
The long-term growth strategy will likely lead to sustained benefits, reflected in stock price over time. Successful execution on their outlined goals can significantly enhance their market position and financial health.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today issued the following statement:
Our Board of Directors and management team are steadfast in our commitment to enhancing long-term shareholder value. We regularly communicate with our shareholders regarding our value creation plan and welcome constructive input as we move forward.
At Acadia, our mission is to create a world-class organization that sets the standard of excellence in the treatment of behavioral health and substance use disorders, and we are executing a focused strategy to position Acadia for the future. Our actions are centered on disciplined growth to expand access to high-quality behavioral healthcare, strengthening clinical outcomes and driving operational efficiency across our national network. At the same time, we are optimizing our portfolio to unlock cash flow, strengthen our financial position and support sustainable, long-term growth.
We remain focused on enhancing value for all shareholders, and our Board regularly evaluates all opportunities to achieve that goal as we work to advance our mission to improve the lives of all those in need of behavioral healthcare.
Goldman Sachs and J.P. Morgan are serving as financial advisors and Kirkland & Ellis LLP is serving as legal advisor to the Company.
About Acadia
Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2025, Acadia operated a network of 274 behavioral healthcare facilities with approximately 12,100 beds in 39 states and Puerto Rico. With approximately 25,000 employees serving more than 82,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.
Forward-Looking Information
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements related to our strategy, growth, anticipated operating results for future periods and our share repurchase program. Generally, words such as "may," "will," "should," "could," "anticipate," "expect," "intend," "estimate," "plan," "continue," and "believe" or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this press release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of our facility expansions, acquisitions, joint ventures and de novo transactions; (ii) Acadia's ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from government and commercial payors, including because of the significant changes to Medicaid financing mechanisms introduced by the One Big Beautiful Bill Act ("OBBBA") enacted on July 4, 2025; (iv) the occurrence of patient incidents, governmental investigations, litigation and adverse regulatory actions, which could adversely affect the price of our common stock and result in substantial payments and incremental regulatory burdens; (v) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; (vi) potential disruptions to our information technology systems or a cybersecurity incident; and (vii) potential operating difficulties, including, without limitation, disruption to the U.S. economy and financial markets; reduced admissions and patient volumes, including, without limitation, due to OBBBA's introduction of work or community engagement requirements in the Medicaid expansion population; increased costs relating to labor, supply chain and other expenditures; changes in competition and client preferences; and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategies. These factors and others are more fully described in Acadia's Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent periodic reports and other filings with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250924145389/en/
Media:
Andi Rose / Mahmoud Siddig / Thomas Crosson
Joele Frank, Wilkinson Brimmer Katcher
arose@joelefrank.com / msiddig@joelefrank.com / tcrosson@joelefrank.com
(212) 355-4449
Investors:
Patrick Feeley
Senior Vice President, Investor Relations
(615) 861-6000
Patrick.Feeley@acadiahealthcare.com